Home > Publications database > Interrupted Time-Series Analysis to Evaluate the Impact of a National Antimicrobial Stewardship Campaign on Antibiotic Prescribing: A Typical Practice in China’s Primary Care > print

001     178414
005     20240229133806.0
024 7 _ |2 doi
|a 10.1093/cid/ciaa962
024 7 _ |2 ISSN
|a 0162-0886
024 7 _ |2 ISSN
|a 1058-4838
024 7 _ |2 ISSN
|a 1537-6591
024 7 _ |a altmetric:85608523
|2 altmetric
024 7 _ |a pmid:32649745
|2 pmid
037 _ _ |a DKFZ-2022-00041
082 _ _ |a 610
100 1 _ |a Li, Hui
|b 0
245 _ _ |a Interrupted Time-Series Analysis to Evaluate the Impact of a National Antimicrobial Stewardship Campaign on Antibiotic Prescribing: A Typical Practice in China’s Primary Care
260 _ _ |a Oxford
|b Oxford Journals
|c 2021
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1641821302_31476
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
536 _ _ |0 G:(DE-HGF)POF4-313
|a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Gong, Yanhong
|b 1
700 1 _ |a Han, Jing
|b 2
700 1 _ |a Zhang, Shengchao
|b 3
700 1 _ |a Chen, Shanquan
|b 4
700 1 _ |0 P:(DE-He78)62b0f1b5eccef2b5f2e55b7f13ccde6d
|a Xu, Xing
|b 5
|u dkfz
700 1 _ |a Lu, Zuxun
|b 6
700 1 _ |0 0000-0002-5020-2984
|a Yin, Xiaoxv
|b 7
773 _ _ |0 PERI:(DE-600)2002229-3
|a 10.1093/cid/ciaa962
|g Vol. 73, no. 11, p. e4463 - e4471
|n 11
|p e4463 - e4471
|t Clinical infectious diseases
|v 73
|x 0162-0886
|y 2021
909 C O |o oai:inrepo02.dkfz.de:178414
|p VDB
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)62b0f1b5eccef2b5f2e55b7f13ccde6d
|a Deutsches Krebsforschungszentrum
|b 5
|k DKFZ
913 1 _ |0 G:(DE-HGF)POF4-313
|1 G:(DE-HGF)POF4-310
|2 G:(DE-HGF)POF4-300
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|a DE-HGF
|b Gesundheit
|l Krebsforschung
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |0 StatID:(DE-HGF)0420
|2 StatID
|a Nationallizenz
|d 2021-01-30
|w ger
915 _ _ |0 StatID:(DE-HGF)0430
|2 StatID
|a National-Konsortium
|d 2021-01-30
|w ger
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b CLIN INFECT DIS : 2019
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)0320
|2 StatID
|a DBCoverage
|b PubMed Central
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2021-01-30
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
|b CLIN INFECT DIS : 2019
|d 2021-01-30
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21